CEO Message

Message from President and CEO

It is our mission to make steady progress in our pipeline and deliver innovative new drugs from Japan to patients all over the world.

We are a one of biotech venture companies challenging innovative drug creations with our own drug creation engines.

It is not easy to create candidates for new drugs and deliver them to patients because a success probability of new drugs is about 1-in-30,000 in general. Yet, we are aiming for the success of new drugs based on our history and achievements of protein kinase inhibitor development over 30 years.
Our development pipelines are innovative in having a “first mechanism in the world” that is different from existing drugs, and targeting a part of diseases for which there is no therapeutic drugs in Japan. We consider them to be “first in Japan” and “breakthrough new drugs” with extremely high value.

We will carry out a social mission to provide new drugs with a high level of therapeutic satisfaction and strive to undertake transparent and reliable management aiming at further growth so that we will be needed by a society.
Your further understanding and support will be appreciated.

President and CEO Yuichi Hidaka